Joseph Yeboah1, David A Bluemke2, W Gregory Hundley3, Carlos J Rodriguez4, Joao A C Lima5, David M Herrington4. 1. Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina; Department of Cardiology, Wake Forest University School of Medicine, Winston-Salem, North Carolina; Department of Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, North Carolina. Electronic address: jyeboah@wakehealth.edu. 2. National Institutes of Health Clinical Center, Bethesda, Maryland. 3. Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina; Department of Cardiology, Wake Forest University School of Medicine, Winston-Salem, North Carolina. 4. Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina; Department of Cardiology, Wake Forest University School of Medicine, Winston-Salem, North Carolina; Department of Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, North Carolina. 5. Cardiology and Radiology, Johns Hopkins University, Baltimore, Maryland.
Abstract
BACKGROUND: Limited data exist on the association between left ventricular (LV) dilation/remodeling and incident heart failure (HF), especially in adults without prior myocardial infarction (MI) and valvular heart disease. We assessed the association between LV dilation and remodeling and incident HF in a multiethnic cohort. METHODS AND RESULTS: A total of 4,974 of 6,814 participants in the Multi-Ethnic Study of Atherosclerosis (MESA) had cardiac magnetic resonance imaging and complete data. Kaplan-Meier and Cox proportional hazard analyses were used to assess the association between LV end-diastolic diameter (LVEDD) and adjudicated HF. During the 12 years of follow-up (mean 9.4 y), 177 (3.6%) HF events occurred, 126 (71.2%) in HF with reduced ejection fraction (EF) and 51 (28.8%) in HF with preserved EF. LV dilation (LVEDD >52 mm or >95th percentile) was associated with HF in univariate (hazard ratio [HR] 1.21, 95% confidence interval [CI] 1.08-1.46; P = .007) and multivariable Cox models (HR 1.28, 95% CI 1.09-1.57; P = .01) adjusting for traditional risk factors, medication use, LV EF, and interim MI. We found a significant multiplicative interaction between LVEDD and LV EF in our full multivariable models. Participants with dilated LV and preserved EF had increased risk [HR 2.22, 95% CI 1.46-3.37; P = .006) and those with dilated LV and reduced EF had worse prognosis (HR 7.35, 95% CI 2.36-22.85; P = .0006) compared with normal-size LV and preserved EF. A high proportion of participants with LV dilation had eccentric remodeling, a risk factor for HF. Concentric hypertrophy, also a risk factor for HF, was common in the normal-size LV group. CONCLUSIONS: LV dilation predicts incident HF independently from risk factors, LV EF, and interim MI.
BACKGROUND: Limited data exist on the association between left ventricular (LV) dilation/remodeling and incident heart failure (HF), especially in adults without prior myocardial infarction (MI) and valvular heart disease. We assessed the association between LV dilation and remodeling and incident HF in a multiethnic cohort. METHODS AND RESULTS: A total of 4,974 of 6,814 participants in the Multi-Ethnic Study of Atherosclerosis (MESA) had cardiac magnetic resonance imaging and complete data. Kaplan-Meier and Cox proportional hazard analyses were used to assess the association between LV end-diastolic diameter (LVEDD) and adjudicated HF. During the 12 years of follow-up (mean 9.4 y), 177 (3.6%) HF events occurred, 126 (71.2%) in HF with reduced ejection fraction (EF) and 51 (28.8%) in HF with preserved EF. LV dilation (LVEDD >52 mm or >95th percentile) was associated with HF in univariate (hazard ratio [HR] 1.21, 95% confidence interval [CI] 1.08-1.46; P = .007) and multivariable Cox models (HR 1.28, 95% CI 1.09-1.57; P = .01) adjusting for traditional risk factors, medication use, LV EF, and interim MI. We found a significant multiplicative interaction between LVEDD and LV EF in our full multivariable models. Participants with dilated LV and preserved EF had increased risk [HR 2.22, 95% CI 1.46-3.37; P = .006) and those with dilated LV and reduced EF had worse prognosis (HR 7.35, 95% CI 2.36-22.85; P = .0006) compared with normal-size LV and preserved EF. A high proportion of participants with LV dilation had eccentric remodeling, a risk factor for HF. Concentric hypertrophy, also a risk factor for HF, was common in the normal-size LV group. CONCLUSIONS: LV dilation predicts incident HF independently from risk factors, LV EF, and interim MI.
Authors: Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart Journal: J Am Soc Echocardiogr Date: 2005-12 Impact factor: 5.251
Authors: Johannes Greupner; Elke Zimmermann; Andrea Grohmann; Hans-Peter Dübel; Till F Althoff; Till Althoff; Adrian C Borges; Wolfgang Rutsch; Peter Schlattmann; Bernd Hamm; Marc Dewey Journal: J Am Coll Cardiol Date: 2012-05-22 Impact factor: 24.094
Authors: S A Hunt; D W Baker; M H Chin; M P Cinquegrani; A M Feldman; G S Francis; T G Ganiats; S Goldstein; G Gregoratos; M L Jessup; R J Noble; M Packer; M A Silver; L W Stevenson; R J Gibbons; E M Antman; J S Alpert; D P Faxon; V Fuster; A K Jacobs; L F Hiratzka; R O Russell; S C Smith Journal: J Am Coll Cardiol Date: 2001-12 Impact factor: 24.094
Authors: Carlos J Rodriguez; Ana V Diez-Roux; Andrew Moran; Zhezhen Jin; Richard A Kronmal; Joao Lima; Shunichi Homma; David A Bluemke; R Graham Barr Journal: J Am Coll Cardiol Date: 2010-01-19 Impact factor: 24.094
Authors: Shunsuke Natori; Shenghan Lai; J Paul Finn; Antoinette S Gomes; W Gregory Hundley; Michael Jerosch-Herold; Gregory Pearson; Shantanu Sinha; Andrew Arai; Joao A C Lima; David A Bluemke Journal: AJR Am J Roentgenol Date: 2006-06 Impact factor: 3.959
Authors: M A Pfeffer; E Braunwald; L A Moyé; L Basta; E J Brown; T E Cuddy; B R Davis; E M Geltman; S Goldman; G C Flaker Journal: N Engl J Med Date: 1992-09-03 Impact factor: 91.245
Authors: Stephen T Broughton; Wesley T O'Neal; Mouaz Al-Mallah; David A Bluemke; Susan R Heckbert; Joao A C Lima; Elsayed Z Soliman Journal: Int J Cardiol Date: 2017-12-15 Impact factor: 4.164
Authors: Ambarish Pandey; Hassan Khan; Anne B Newman; Edward G Lakatta; Daniel E Forman; Javed Butler; Jarett D Berry Journal: Hypertension Date: 2016-12-19 Impact factor: 10.190
Authors: M S Burroughs Peña; E J Velazquez; J D Rivera; F Alenezi; C Wong; M Grigsby; V G Davila-Roman; R H Gilman; J J Miranda; W Checkley Journal: Indoor Air Date: 2017-01-16 Impact factor: 5.770
Authors: Hooman Bakhshi; Bharath Ambale-Venkatesh; Xiaoying Yang; Mohammad R Ostovaneh; Colin O Wu; Matthew Budoff; Hossein Bahrami; Nathan D Wong; David A Bluemke; João A C Lima Journal: J Am Heart Assoc Date: 2017-04-20 Impact factor: 5.501
Authors: Melissa Burroughs Peña; Katrina Swett; Neil Schneiderman; Daniel M Spevack; Sonia G Ponce; Gregory A Talavera; Mayank M Kansal; Martha L Daviglus; Jianwen Cai; Barry E Hurwitz; Maria M Llabre; Carlos J Rodriguez Journal: BMJ Open Diabetes Res Care Date: 2018-08-13
Authors: Nay Aung; Jose D Vargas; Chaojie Yang; Claudia P Cabrera; Helen R Warren; Kenneth Fung; Evan Tzanis; Michael R Barnes; Jerome I Rotter; Kent D Taylor; Ani W Manichaikul; Joao A C Lima; David A Bluemke; Stefan K Piechnik; Stefan Neubauer; Patricia B Munroe; Steffen E Petersen Journal: Circulation Date: 2019-09-25 Impact factor: 29.690